Grabarek, B., Krzaczyński, J., Strzałka‐Mrozik, B., Wcisło‐Dziadecka, D., & Gola, J. (2019). The influence of ustekinumab on expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in patients with psoriasis and in a control. Dermatologic therapy, 32(5), e13029-n/a. https://doi.org/10.1111/dth.13029
Chicago-Zitierstil (17. Ausg.)Grabarek, Beniamin, Jakub Krzaczyński, Barbara Strzałka‐Mrozik, Dominika Wcisło‐Dziadecka, und Joanna Gola. "The Influence of Ustekinumab on Expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in Patients with Psoriasis and in a Control." Dermatologic Therapy 32, no. 5 (2019): e13029-n/a. https://doi.org/10.1111/dth.13029.
MLA-Zitierstil (9. Ausg.)Grabarek, Beniamin, et al. "The Influence of Ustekinumab on Expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in Patients with Psoriasis and in a Control." Dermatologic Therapy, vol. 32, no. 5, 2019, pp. e13029-n/a, https://doi.org/10.1111/dth.13029.